Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Therapy areas
Immuno-inflammation
Immuno-inflammation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
Johnson & Johnson reports positive results for Stelara using “treat-to-target” approach in Phase III Crohn’s disease trial
Firstwordpharma News
-
February 14, 2020
Immuno-inflammation
Physician Views snap poll: AbbVie builds out clinical case for Rinvoq in psoriatic arthritis; how do rheumatologists perceive the data?
Immuno-inflammation
AbbVie’s SKYRIZI Now Publicly Reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the Treatment of Moderate to Severe Plaque Psoriasis
Immuno-inflammation
Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen
Immuno-inflammation
Penn Researchers Identify Cancer Cell Defect Driving Resistance to CAR T Cell Therapy
Immuno-inflammation
Discovery would allow researchers to fine-tune CAR-T activity
Firstwordpharma News
-
January 30, 2020
0
Immuno-inflammation
Hansa Biopharma Completes Enrollment in Anti-GBM
Biospace News
-
January 27, 2020
0
Immuno-inflammation
Drug profiling and gene scissors open new avenues in immunotherapy
Firstwordpharma News
-
January 22, 2020
0
Immuno-inflammation
ICER Issues Final Report and Policy Recommendations on JAK Inhibitors for...
Firstwordpharma News
-
January 9, 2020
0
Immuno-inflammation
Durect Drug Fails to Shine in Mid-Stage Plaque Psoriasis Trial
Biospace News
-
January 3, 2020
0
1
2
3
...
8
Page 1 of 8
- Advertisement -
MOST POPULAR
Hoth Therapeutics And North Carolina State University Initiate Preclinical Gene Therapy...
December 9, 2019
ADC Therapeutics reports positive data from pivotal study of loncastuximab tesirine...
January 9, 2020
Karuna Therapeutics Schedules Webcast and Conference Call to Announce Results from...
November 17, 2019
Dermira’s lebrikizumab gains FDA fast-track status for atopic dermatitis
December 10, 2019
Load more
HOT NEWS
Phase I
EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase...
Others
CRI scientists discover metabolic feature that allows melanoma cells to spread
Others
Artificial intelligence yields new antibiotic
Others
Dynavax to Lay Off 37% of Staff, CEO to Retire as...
